• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Fri, Jul 25, 2025
Home » BioWorld data methodology
Email
Tweet

BioWorld data methodology

Clinical

BioWorld biopharma clinical, regulatory and conference charts include worldwide news of phase I, phase II and phase III clinical development by biopharmaceutical companies developing therapeutics, as well as all actions by global regulatory authorities and clinical data reported at industry conferences. Collected from BioWorld.

Deals

BioWorld biopharma deals charts include all global for-profit licensings, collaborations, joint ventures and various other agreements in which at least one party is a biopharmaceutical company developing therapeutics. Nonprofit deals between biopharma companies and government entities or nonprofit institutions are separated into their own category. Collected from BioWorld and Cortellis.

BioWorld MedTech deals charts include all global for-profit licensings, collaborations, joint ventures and various other agreements in which at least one party is a medical device, diagnostic or other company involved in developing medical technology products. Collected from BioWorld and Cortellis.

BioWorld Asia deals charts include all for-profit licensings, collaborations, joint ventures and various other agreements in which at least one party is based in Asia and a biopharmaceutical company developing therapeutics. Collected from BioWorld and Cortellis.

Financings

BioWorld biopharma financings charts include all global public and private financings, including IPOs (listings on Canadian, U.S. and European, Australian, Hong Kong and China exchanges), follow-ons, private placements and venture capital rounds, as well as loans, of biopharmaceutical companies developing therapeutics. They do not include grants or money received through deals. Collected from BioWorld.

BioWorld biopharma grants charts include all grants received by biopharmaceutical companies developing therapeutics from government and nonprofit entities. Collected from BioWorld and Cortellis.

BioWorld MedTech financings charts includes all global public and private financings, including IPOs, follow-ons, private placements and venture capital rounds, as well as loans, of medical device, diagnostic and other companies developing medical technology products. They do not include grants or money received through deals. Collected from BioWorld.

BioWorld Asia biopharma financings charts include all public and private financings, including IPOs, follow-ons, private placements and venture capital rounds, as well as loans, of biopharmaceutical companies, based in Asia, that are developing therapeutics. They do not include grants or money received through deals. Collected from BioWorld.

Indexes

The BioWorld biopharma stock index includes more than 500 U.S. stocks of biopharmaceutical companies developing therapeutics.

The BioWorld MedTech stock index includes about 230 U.S. stocks of medical device, diagnostic and other companies developing medical technology products.

The BioWorld Asia biopharma stock index includes 20 stocks of Asian biopharmaceutical companies developing therapeutics.

M&As

BioWorld biopharma M&A charts include all completed global mergers and acquisitions in which at least one party is a biopharmaceutical company developing therapeutics. Collected from BioWorld and Cortellis.

BioWorld MedTech M&A charts include all completed global mergers and acquisitions in which at least one party is a medical device, diagnostic or other company involved in developing medical technology products. Collected from BioWorld and Cortellis.

U.S. FDA Approvals

BioWorld's coverage of drugs approved by the U.S. FDA includes supplementals for new indications but does not include over-the-counter medicines, new doses or generic approvals for already counted drugs. See here for the FDA's glossary of terms.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 25, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 25, 2025.
  • Brain and neural networks

    Proteomics finds surprise commonalities as well as differences in neurodegenerative diseases

    BioWorld
    The switch will be flicked today to make the world’s largest dementia-related proteomics dataset freely available to researchers, at the same time as members of...
  • Roche building

    Roche receives CE Mark for Alzheimer’s rule out test

    BioWorld MedTech
    Roche Holding AG received CE mark for its Elecsys pTau181 test to help rule out Alzheimer’s disease. The minimally invasive blood test, developed in collaboration...
  • Autoantibodies bond to receptor blocking the acetylcholine transmitters in myasthenia gravis

    Phase III MG settee: Astrazeneca perched pretty with gefurulimab

    BioWorld
    Astrazeneca plc seems on the way to expanding its presence in myasthenia gravis (MG) with positive “high-level” results from a global, randomized, double-blind,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe